Iterative acylation on mature lasso peptides by widespread acetyltransferases for lipolasso production
Xiong, J.; Wu, S.; Liang, Z.-Q.; Fang, S.; Tao, F.-Y.; Gong, X.-T.; Wu, Q.; Cui, J.-J.; Gao, K.; Luo, S.; Lei, D.; Dong, S.-H.
Show abstract
The biosynthesis of ribosomally synthesized and post-translationally modified peptides (RiPPs) leverages iterative catalysis to enhance structural and biological diversity. Traditionally, iterative enzymes install multiple post-translational modifications (PTMs) on linear peptides, rather than mature RiPPs with intricate three-dimensional structures, which would require complex changes in substrate binding poses. Here, we present a prolific class of GCN5-related N-acetyltransferases (GNATs) that iteratively and consecutively acylate two Lys residues within the loop and ring motifs of lasso peptides, diverging from the typical iterative modification of linear peptides--an unprecedented function for PTM enzymes. Utilizing high-resolution cryo-electron microscopy and enzymatic reconstitution, we mapped the lasso peptide binding pocket of IatT and pinpointed key residues involved in demarcating the two distinct acetylation steps. Structure-based engineering of IatTs acetyl group recognition site expanded the cavity to accommodate longer-chain acyl groups, leading to the creation of lipolasso peptides, a novel class of ribosomal lipopeptide. This engineering strategy can be applied to any RiPP BGC encoding GNAT, facilitating the efficient diversification of rare ribosomal lipopeptides. Graphic Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=95 SRC="FIGDIR/small/630886v1_ufig1.gif" ALT="Figure 1"> View larger version (30K): org.highwire.dtl.DTLVardef@1d88af9org.highwire.dtl.DTLVardef@18c1298org.highwire.dtl.DTLVardef@118b9f3org.highwire.dtl.DTLVardef@580a50_HPS_FORMAT_FIGEXP M_FIG C_FIG
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Gut microbiota-derived GlcNAc-MurNAc is a TLR4 agonist that protects the host gut 96%
- Discovery of orally bioavailable SARS-CoV-2 papain-like protease inhibitor as a potential treatment for COVID-19 95%
- Genetic and functional diversity of beta-N-acetylgalactosamine residue-targeting glycosidases expanded by deep-sea metagenome 95%
Similar papers in this journal
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.